IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP II, LLC

Q4 2017 Holdings

Filed 2018-02-13 | 5 holdings | $555.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Blueprint Medicines Corporation(2L9)COM09627Y109$185.0K2,453,75333.3%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$130.4K10,230,34923.5%
Myokardia, Inc.COM62857M105$121.5K2,885,10421.9%
Sage Therapeutics, Inc.(SG7)COM78667J108$90.2K547,91616.3%
Allena Pharmaceuticals, Inc.(ALNAEUR)COM018119107$28.1K2,790,9645.1%